Publicaciones en las que colabora con María Isabel de José Gómez (63)

2017

  1. Low Bone Mineral Density in Vertically HIV-infected Children and Adolescents: Risk Factors and the Role of T-cell Activation and Senescence

    Pediatric Infectious Disease Journal

  2. Prediction of long-term outcomes of HIV-infected patients developing non-AIDS events using a multistate approach

    PLoS ONE, Vol. 12, Núm. 9

2016

  1. Impact of late presentation of HIV infection on short-, mid- and long-term mortality and causes of death in a multicenter national cohort: 2004-2013

    Journal of Infection, Vol. 72, Núm. 5, pp. 587-596

  2. Relationship between plasma bilirubin level and oxidative stress markers in HIV-infected patients on atazanavir- vs. efavirenz-based antiretroviral therapy

    HIV Medicine, Vol. 17, Núm. 9, pp. 653-661

2015

  1. Cardiac function in vertically HIV-infected children and adolescents in the era of highly active antiretroviral therapy

    Pediatric Infectious Disease Journal, Vol. 34, Núm. 5, pp. e125-e131

  2. Lipid and glucose alterations in perinatally-acquired HIV-infected adolescents and young adults

    BMC Infectious Diseases, Vol. 15, Núm. 1

2014

  1. Birth defects in a cohort of infants born to HIV-infected women in Spain, 2000-2009

    BMC Infectious Diseases, Vol. 14, Núm. 1

  2. Cardiovascular biomarkers in vertically HIV-infected children without metabolic abnormalities

    Atherosclerosis, Vol. 233, Núm. 2, pp. 410-414

  3. Determinants of highly active antiretroviral therapy duration in HIV-1-infected children and adolescents in Madrid, Spain, from 1996 to 2012

    PLoS ONE, Vol. 9, Núm. 5

  4. Subclinical atherosclerosis and markers of immune activation in hiv-infected children and adolescents: The carovih study

    Journal of Acquired Immune Deficiency Syndromes, Vol. 65, Núm. 1, pp. 42-49

2013

  1. A new tool for the paediatric HIV research: General data from the Cohort of the Spanish Paediatric HIV Network (CoRISpe)

    BMC Infectious Diseases

  2. Implementation of Occult Hepatitis Screening in the Spanish Cohort of HIV-infected Pediatric Patients

    Pediatric Infectious Disease Journal, Vol. 32, Núm. 9, pp. e377-e379

  3. The CD4/CD8 ratio as a marker T-cell activation, senescence and activation/exhaustion in treated HIV-infected children and young adults

    AIDS, Vol. 27, Núm. 9, pp. 1513-1516

2012

  1. High Drug Resistance Prevalence among Vertically HIV-Infected Patients Transferred from Pediatric Care to Adult Units in Spain

    PLoS ONE, Vol. 7, Núm. 12

  2. High prevalence of X4/DM-tropic variants in children and adolescents infected with HIV-1 by vertical transmission

    Pediatric Infectious Disease Journal, Vol. 31, Núm. 10, pp. 1048-1052

  3. Low rates of mother-to-child transmission of HIV-1 and risk factors for infection in Spain: 2000-2007

    Pediatric Infectious Disease Journal, Vol. 31, Núm. 10, pp. 1053-1058

  4. Nuevos diagnósticos de infección VIH en niños

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 30, Núm. 3, pp. 131-136

  5. Potent and sustained antiviral response of raltegravir-based highly active antiretroviral therapy in HIV type 1-infected children and adolescents

    Pediatric Infectious Disease Journal, Vol. 31, Núm. 3, pp. 273-277

  6. Trends in Drug Resistance Prevalence in HIV-1-infected Children in Madrid: 1993 to 2010 Analysis

    Pediatric Infectious Disease Journal, Vol. 31, Núm. 11, pp. e213-e221

2011

  1. Cardiovascular risk markers are increased in HIV-infected children with lipodystrophy syndrome

    Journal of Infection